We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

69 hedge funds and large institutions have $1.96B invested in Praxis Precision Medicines in 2020 Q4 according to their latest regulatory filings, with 69 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6.31% more ownership

Funds ownership: 0% → 6.31% (+6.3%)

Holders
69
Holders Change
+69
Holders Change %
–
% of All Funds
1.22%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.11%
New
69
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Blackstone Inc
Blackstone Inc
New York
+$331M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$140M
3
EAM
Eventide Asset Management
Massachusetts
+$137M
4
VVA
Vida Ventures Advisors
Massachusetts
+$114M
5
NHAS
Novo Holdings A/S
Denmark
+$95M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Blackstone Inc
1
Blackstone Inc
New York
$468M +$331M +566,766 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$198M +$140M +240,401 New
EAM
3
Eventide Asset Management
Massachusetts
$184M +$137M +234,205 New
VVA
4
Vida Ventures Advisors
Massachusetts
$162M +$114M +195,955 New
NHAS
5
Novo Holdings A/S
Denmark
$134M +$95M +162,805 New
Citadel Advisors
6
Citadel Advisors
Florida
$87.8M +$62.1M +106,376 New
ACA
7
Avoro Capital Advisors
New York
$68.7M +$60.1M +103,033 New
BlackRock
8
BlackRock
New York
$65.9M +$46.6M +79,826 New
CAM
9
Cormorant Asset Management
Massachusetts
$57.7M +$41.8M +71,610 New
7IH
10
72 Investment Holdings
Connecticut
$54.4M +$38.5M +65,933 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$54.1M +$38.3M +65,541 New
Janus Henderson Group
12
Janus Henderson Group
United Kingdom
$49.4M +$34.9M +59,825 New
HMC
13
Harvard Management Company
Massachusetts
$43.6M +$30.8M +52,841 New
AG
14
Artal Group
Luxembourg
$41.3M +$29.2M +50,000 New
AllianceBernstein
15
AllianceBernstein
Tennessee
$38.3M +$27.1M +46,417 New
Verition Fund Management
16
Verition Fund Management
Connecticut
$31.6M +$22.4M +38,297 New
Adage Capital Partners
17
Adage Capital Partners
Massachusetts
$22.7M +$16M +27,472 New
MWNA
18
Marshall Wace North America
New York
$20.4M +$14.4M +24,752 New
DM
19
Deerfield Management
New York
$19.3M +$13.6M +23,333 New
WP
20
Woodline Partners
California
$16.6M +$11.8M +20,136 New
O
21
OrbiMed
New York
$14.1M +$9.95M +17,040 New
FCM
22
Farallon Capital Management
California
$13.8M +$9.73M +16,667 New
Franklin Resources
23
Franklin Resources
California
$13.8M +$9.73M +16,667 New
Point72 Asset Management
24
Point72 Asset Management
Connecticut
$13.8M +$9.73M +16,667 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$11.3M +$7.98M +13,670 New
1
2 3

PRAX Hedge Fund Activity: Q4 2020 in Review

69 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q4 2020, worth a combined $1.96B.

Buyers outnumbered sellers: 69 funds opened new PRAX positions and 0 closed out — a net gain of 69 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Blackstone Inc, opening a new position worth an estimated $331M.

  • 69 institutional investors held Praxis Precision Medicines (PRAX) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $1.96B of Praxis Precision Medicines stock for Q4 2020.
  • 69 funds opened new Praxis Precision Medicines positions in Q4 2020 and 0 closed out, a net change of +69 holders.
  • The largest Praxis Precision Medicines buyer in Q4 2020 was Blackstone Inc, an estimated $331M added.

Based on aggregated 13F filings for Q4 2020.